In addition, we demonstrate that the methylation status of these regulatory regions is associated with endocrine resistance in human disease, thus providing a novel mechanism by which endocrine response is abated in ESR1-positive breast cancers. The gene discussed is ESR1; the disease is breast carcinoma.